This comprehensive website provides links to resources for the intersection of the opioid crisis and the coronavirus pandemic, makes available previously reported webinars on supporting addiction treatment during the pandemic, and lists several commentaries in academic journals written by experts in the field.
Treatment Resources
- COVID / Coronavirus related
This is the website of the National Academy of Medicine's Opioid Collaborative, which provides webinars, discussion papers, and other resources on addressing the opioid crisis.
- Educational
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Hospitals
- Medical
- Policymakers
This is a 2020 report from the Office of National Drug Control Policy (ONDCP) that discusses the strategic priorities of the federal government in relation to the supply and demand of drugs and how these will be operationalized. There is a focus on prevention, treatment, and recovery strategies.
- Cautious Opioid Prescribing
- Housing, Education, and Employment
- Medications for Opioid Use Disorder
- Overdose prevention
- Recovery coaching
- Community Coalitions
- Criminal Justice
- Law Enforcement
- Policymakers
This report describes model criteria for certifying peer support workers to ensure their competence in providing substance and/or mental health peer support services. Such criteria include providing evidence of understanding of lived experience with substances, training in core competencies, formal education in relevant disciplines, and having supervised work experience.
- Outreach
- Post-overdose response
- Recovery coaching
- Advocates / Peers
This is a report from the American Medical Association and Manatt Health that examines the response to the opioid crisis in four different states. Within this document, state-level efforts in six key areas were analyzed to identify best practices and provide a road map for all states to follow to mount a comprehensive response to the opioid crisis.
- Cautious Opioid Prescribing
- Medications for Opioid Use Disorder
- Overdose prevention
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
- Policymakers
A national survey of treatment providers done every year which can help assess the nature and extent of the services provided and in forecasting treatment resource requirements as well as analyze general treatment services trends.
- Policymakers
This editorial highlights the consequences of a lack of real time data on drug overdose deaths. The authors discuss how with access to reliable and timely data, healthcare policymakers can implement strategies that identify and target specific at risk populations.
- Comprehensive services
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Policymakers
This is a presentation by several collaborating organizations that describes the community response to the opioid crisis addressing upstream, midstream, and downstream interventions, such as cautious opioid prescribing, medications for opioid use disorder, and overdose prevention, respectively.
- Cautious Opioid Prescribing
- Medications for Opioid Use Disorder
- Overdose prevention
- Community Coalitions
- Community Health Officials
- Policymakers
This is an academic paper that provides an overview of the neurobiology and neuroscience of opioid use disorder (OUD), with diagrams showing the parts of the brain affected and the science underlying the high risk of recurrence of OUD symptoms.
- Educational
- Addiction Treatment Providers
- Community Health Officials
- Medical
This federally-funded resource center provides a comprehensive list of resources and research specific to telehealth in substance use disorder treatment.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Medical
- Policymakers
The Ohio Mental Health and Addiction Services Coronavirus Opioid Treatment Providers FAQ gives these organizations guidance on navigating state and federal regulations for methadone and buprenorphine during the Covid pandemic.
- COVID / Coronavirus related
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Community Health Officials
- Policymakers
This is an academic paper that examines polysubstance use disorders, the need for treatment systems to account for their high prevalence, and the high risks of developing more than one substance use disorder. For example, the increased risk of developing heroin dependence is twofold for alcohol misusers, threefold for cannabis users, 15-fold for cocaine users, and 40-fold for prescription misusers. Behavioral and neural circuitry in the context of co-use of substance is explored.
- Educational
- Addiction Treatment Providers
- Community Health Officials
- Medical